Citation Tools

Original research
Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancer

Download to a citation manager

Cite this article as:
McNeel DG, Emamekhoo H, Eickhoff JC, et al
Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancer